tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences

Need an answer now?

Give us a call

Leave a message, we'll get back to you

Human and Viral SARS-CoV-2 screening kits

Human and Viral proteases have been shown as essential for the entry and replication of SARS-CoV-2 into human cells.

These results have made such enzymes promising targets for the development of a new coronavirus treatment.
To accompany researchers working on this topic, tebu-bio provides a full set of screening assays to identify new inhibitor compounds against these enzymes.

Developed in a convenient 96 well format, these screening kits will allow you to quickly identify new potential drugs targeted these promising proteases.

Get your projects fast-tracked!

Our laboratory based near Paris (France) has developed and performs many services to help you in evaluating your current drug portfolio or lead NMEs for anti-COVID-19 therapeutic purposes, but also numerous other research fields.

Interested in testing your portfolio with our SARS-CoV-2/ACE2 in vitro screening assays?
Or testing directly in a physiologically relevant context thanks to these new pseudovirus tools?

Interested in learning more?



Find more in-depth information about these new screening assays in this post on our blog.